Cargando…
Lymphomatoid papulosis in a patient treated with glatiramer acetate and the glatiramoid Glatopa for multiple sclerosis: A case report
A 48-year-old Caucasian woman with history of multiple sclerosis (MS) presented with erythematous papulonodular lesions in her extremities and trunk. She was being treated with glatiramer acetate (GA) for the past 10 years and the glatiramoid, Glatopa, for 2 years prior to this presentation. A skin...
Autores principales: | Shirani, Afsaneh, Dalton, Scott R, Avery, Eric J, Arcot Jayagopal, Lakshman, Meyer, Christina, Stuve, Olaf, Zabad, Rana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606967/ https://www.ncbi.nlm.nih.gov/pubmed/34819759 http://dx.doi.org/10.1177/11795735211053784 |
Ejemplares similares
-
Development of Glatopa® (Glatiramer Acetate): The First FDA-Approved Generic Disease-Modifying Therapy for Relapsing Forms of Multiple Sclerosis
por: Bell, Christine, et al.
Publicado: (2017) -
Anti-Neurofascin Antibodies Associated with White Matter Diseases of the Central Nervous System: A Red Flag or a Red Herring?
por: Gupta, Navnika, et al.
Publicado: (2022) -
Disseminated Aspergillosis in a Patient With Neurosarcoidosis: Persistent Contrast Enhancement in CNS Despite Prolonged Antifungal Treatment: A Case Report
por: Arcot Jayagopal, Lakshman, et al.
Publicado: (2023) -
Type B lymphomatoid papulosis
por: Bouhamidi, Ahmed, et al.
Publicado: (2018) -
A child with mastocytosis and lymphomatoid papulosis
por: Lange, Henriette Juel, et al.
Publicado: (2016)